Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
10947 | 953 | 32.7 | 54% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
662 | 12640 | NOCICEPTIN//ORPHANIN FQ//NOCICEPTIN ORPHANIN FQ |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | DRUG DISCRIMINATION | Author keyword | 62 | 22% | 26% | 251 |
2 | NOVEL RESPONSE PROCEDURE | Author keyword | 8 | 100% | 1% | 5 |
3 | TRAINING DOSE | Author keyword | 7 | 56% | 1% | 9 |
4 | CLOCINNAMOX | Author keyword | 5 | 60% | 1% | 6 |
5 | DISCRIMINATIVE STIMULUS | Author keyword | 5 | 21% | 2% | 20 |
6 | ETHANOL DISCRIMINATION | Author keyword | 4 | 67% | 0% | 4 |
7 | CONCURRENT FIXED RATIO SCHEDULES | Author keyword | 4 | 75% | 0% | 3 |
8 | DRUG DISCRIMINATION LEARNING | Author keyword | 4 | 50% | 1% | 6 |
9 | PAVLOVIAN DRUG DISCRIMINATION | Author keyword | 4 | 75% | 0% | 3 |
10 | THREE CHOICE DRUG DISCRIMINATION | Author keyword | 4 | 75% | 0% | 3 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | DRUG DISCRIMINATION | 39 | 28% | 13% | 122 |
2 | BEHAVIORAL BASELINE | 29 | 88% | 1% | 14 |
3 | MIXED ACTION OPIOIDS | 21 | 75% | 2% | 15 |
4 | MU OPIOIDS | 17 | 43% | 3% | 30 |
5 | STIMULUS PROPERTIES | 16 | 20% | 7% | 69 |
6 | APPARENT PA2 ANALYSIS | 10 | 54% | 1% | 13 |
7 | AGONIST ANTAGONIST OPIOIDS | 10 | 41% | 2% | 19 |
8 | CAFFEINE DISCRIMINATION | 9 | 83% | 1% | 5 |
9 | CUE SENSITIVITY | 9 | 83% | 1% | 5 |
10 | PHENMETRAZINE | 8 | 52% | 1% | 11 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Discriminative stimulus and subjective effects of opioids with mu and kappa activity: Data from laboratory animals and human subjects | 1997 | 42 | 59 | 73% |
Role of training dose in drug discrimination: a review | 2011 | 10 | 138 | 34% |
DRUG DISCRIMINATION BY HUMANS COMPARED TO NONHUMANS - CURRENT STATUS AND FUTURE-DIRECTIONS | 1993 | 84 | 90 | 56% |
SUBJECTIVE AND DISCRIMINATIVE EFFECTS OF DRUGS | 1991 | 79 | 19 | 53% |
Drug discrimination: No evidence for tolerance to opiates | 1995 | 19 | 69 | 67% |
Discriminative stimulus effects of ethanol: Neuropharmacological characterization | 1999 | 51 | 158 | 21% |
Determinants of the behavioral effects of opioids and their antagonists: contributions of the Laboratory of Psychobiology | 2002 | 0 | 7 | 71% |
USE OF INVIVO APPARENT PA(2) ANALYSIS IN ASSESSMENT OF OPIOID ABUSE LIABILITY | 1992 | 17 | 23 | 70% |
DRUG-ABUSE POTENTIAL EVALUATION IN ANIMALS | 1991 | 71 | 17 | 24% |
METHODS FOR MEASURING THE STRENGTH OF DISCRIMINABLE DRUG EFFECTS | 1986 | 24 | 3 | 100% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | SECT BEHAV PHARMACOL | 1 | 15% | 0.8% | 8 |
2 | PHARMACEUT SCI 522 | 1 | 50% | 0.1% | 1 |
3 | PHARMACOL NARCOT | 1 | 50% | 0.1% | 1 |
4 | PSYCHIAT BEHAV SCISUBST ABUSE | 1 | 50% | 0.1% | 1 |
5 | AV VALDMAN PHARMACOL | 0 | 33% | 0.1% | 1 |
6 | OFF CONTROL | 0 | 33% | 0.1% | 1 |
7 | DRUG CHEM EVALUAT SECT | 0 | 18% | 0.2% | 2 |
8 | VA MED RD 12 | 0 | 25% | 0.1% | 1 |
9 | NEW ENGLAND REG PRIMATE MED | 0 | 20% | 0.1% | 1 |
10 | ADARC | 0 | 13% | 0.1% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000160576 | CONTINGENT TOLERANCE//REINFORCEMENT LOSS//CONDITIONED TOLERANCE |
2 | 0.0000121986 | DYNORPHIN//CI 977//DYNORPHIN A |
3 | 0.0000114642 | BEHAVIORAL ECONOMICS//UNIT PRICE//DRUG SELF ADMINISTRATION |
4 | 0.0000099853 | CLING WRAP//DEPENDENCE PRODUCING DRUGS//LONG TERM EVALUATIONS |
5 | 0.0000099065 | BRETAZENIL//ABECARNIL//FLUMAZENIL |
6 | 0.0000091986 | SALVINORIN A//SALVIA DIVINORUM//KAPPA OPIOID RECEPTOR |
7 | 0.0000089695 | MORPHINE WITHDRAWAL//EQUIP CELLULAR MOL PHARMACOL//ACUTE DEPENDENCE |
8 | 0.0000085432 | PHENCYCLIDINE//METAPHIT//CAS 956 90 1 |
9 | 0.0000081749 | NALBUPHINE//MEPTAZINOL//DEZOCINE |
10 | 0.0000080973 | DELTA OPIOID RECEPTOR//DELTA OPIOID AGONIST//SNC80 |